Working together to improve the health of people who use drugs
Join us in Geneva, the world hub of global health and innovation, for over 100 sessions dedicated to the health and well-being of people who use drugs, with tracks on epidemiology, public health, clinical research, and policy development.
Former President of the Swiss Confederation and founding member and former Chair of the Global Commission on Drug Policy
Head of Viral Hepatitis and Opioid Dependency Dept., Public Health Center of the Ministry of Health of Ukraine
Dr. Joaquin Cabezas
Gastroenterology and Hepatology Physician, Marques de Valdecilla University Hospital, Spain
Dr. Behzad Hajarizadeh
Clinical Epidemiologist and Associate Professor, the Kirby Institute, UNSW, Sydney
Dr. Marie Jauffret-Roustide
Sociologist and Research Fellow, French National Institute of Health and Medical Research
Dr. Andrew Seaman
Associate Professor of Medicine at Oregon Health & Sciences University, boarded in Internal and Addiction Medicine.
Scientia Professor Louisa Degenhardt
NHMRC Senior Principal Research Fellow and Deputy Director at the National Drug and Alcohol Research Centre (NDARC), Faculty of Medicine, UNSW, Sydney
Mr Kennedy Kipoech
PhD student at Cape Town and Bristol universities, in SA and UK, respectively
INHSU 2022 welcomed nearly 800 people from over 50 countries, with 2023’s conference in Geneva set to be the biggest yet. The diverse delegation and speakers include people working in the fields of infectious diseases, harm reduction, drug policy and more. Find out why people attend our conference in the videos below.
Geneva is the world hub of global health, scientific research, and innovation. Its unique ecosystem of global health organisations, not-for-profits and academic institutions makes it the ideal location to foster collaboration among diverse stakeholders, facilitating knowledge exchange and policy development, and drive change for one of the world’s most stigmatised and under-served communities.
INHSU is unique due to the cross-collaboration between different stakeholders dedicated to the health of people who use drugs. This leads to a program that facilitates balanced discussions, shared perspectives, and invaluable cross-sector learnings.
Our robust abstract review process includes world-renowned experts reviewing abstracts, with only the highest-ranking invited to present. This is continually proven by the number of studies that go on to be published in leading journals.
Over 100 sessions, including plenary sessions, workshops, posters and networking events. Topics include epidemiology and public health research, clinical research, social science and policy research, good practice models of care.
Pre-conference events include an invite-only policy day seeking to increase coverage of opioid agonist therapy globally, a community day, organised by INHSU’s Community Committee of people who use drugs, and our INHSU Prisons workshop.
- Abstract Submission Deadline: 19 March 2023 – extended to 26 March
- Scholarship Applications Deadline: 19 March 2023 – extended to 26 March
- Late Breaker Abstracts Open: 1 May 2023
- Late Breaker Abstracts Close: 28 May 2023
- Early Bird Registrations Open: 8 May 2023
- Early Bird Registrations Close: 30 July 2023
- Accommodation Close: 10 September 2023
- Standard Registration Close: 17 September 2023